PROTEINA has developed the first-in-class “Single-Molecule Co-Immunoprecipitation”-based general platform, which enables precise measurement of protein-protein interactions (PPIs) at the single-molecular level. At PROTEINA, we’ve spent over a decade delving into the intricacies of protein-protein interactions. The wealth of knowledge and experience we’ve gained is reflected in our diverse range of research services and products that we offer to our clients and research partners. These offerings include biomarker discovery for drug development, deciphering the mechanisms of pharmaceutical compounds, and identifying the ideal drug dose of a specific drug treatment. Ultimately, we see our goal of developing accurate, reliable companion diagnostic devices slowly become a reality.